The weight loss medication Zepbound has gone into shortage just months after it was approved by the Food and Drug Administration (FDA), with its manufacturer Eli Lilly blaming the situation on high demand. As of this week, most tirzepatide injections (sold commercially as Mounjaro and Zepbound) have limited availability, according to the FDA’s shortage database. … Read more
My doctor didn’t tell me I was too fat at my September physical. She didn’t tell me my hemoglobin A1C level was too high — a critical sign of diabetes risk. She didn’t tell me that if I took weight loss drugs my joints would thank me, or I’d feel less anxiety, or I’d live … Read more
Ozempic, the winning diabetes drug that shifted the entire paradigm of the weight loss world, has turned into an in-demand product in recent years. Semaglutide, the clinical name prescribed to the drug for brands such as Mounjaro, and Ozempic has been in less supply for around two years since the manufacturers have been struggling to … Read more
